Literature DB >> 30048777

Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma.

Mona Alibolandi1, Fazileh Hoseini2, Marzieh Mohammadi3, Pouria Ramezani4, Elham Einafshar1, Seyed Mohammad Taghdisi5, Mohammad Ramezani6, Khalil Abnous7.   

Abstract

Gold NPs have great potential in biomedical applications. PAMAM dendrimers are spherical, hyper branched macromolecules which can encapsulate therapeutic molecules while stabilizing metal nanoparticle such as gold NPs. The aim of the current study was to investigate the theranostic capability of curcumin-loaded dendrimer-gold hybrid structure. Dendrimer-gold hybrid structure was synthesized by complexing AuCl4- ions with PEGylated amine-terminated generation 5 poly (amidoamine) dendrimer. The resultant hybrid system was loaded with curcumin. The curcumin-loaded PEGylated Au dendrimer was further conjugated to MUC-1 aptamer in order to target the colorectal adenocarcinoma in vitro and in vivo. Obtained results demonstrated that the targeted theranostic agent was accumulated in HT29 and C26 cells in vitro and showed higher cellular cytotoxicity in comparison with non-targeted system. On the other hand, in vivo experiment demonstrated the potential of targeted theranostic system in CT-scan tumor imaging as well as cancer therapy. Findings from this study suggested that MUC-1 targeted curcumin-loaded PEGylated Au dendrimers have good X-ray attenuation and is desirable probe for CT imaging while demonstrating high therapeutic index against colorectal cancer adenocarcinoma.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CT scan; Colorectal cancer; Curcumin; PAMAM; Theranostic

Mesh:

Substances:

Year:  2018        PMID: 30048777     DOI: 10.1016/j.ijpharm.2018.07.052

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells.

Authors:  Maryam Ghaffari; Gholamreza Dehghan; Behzad Baradaran; Amir Zarebkohan; Behzad Mansoori; Jafar Soleymani; Jafar Ezzati Nazhad Dolatabadi; Michael R Hamblin
Journal:  Colloids Surf B Biointerfaces       Date:  2019-12-27       Impact factor: 5.268

Review 2.  Possible Mechanisms and Special Clinical Considerations of Curcumin Supplementation in Patients with COVID-19.

Authors:  Zinat Heidari; Marzieh Mohammadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy.

Authors:  Seyed Mojtaba Mashmoul Moghadam; Mona Alibolandi; Maryam Babaei; Jafar Mosafer; Amir Sh Saljooghi; Mohammad Ramezani
Journal:  J Biol Inorg Chem       Date:  2020-11-06       Impact factor: 3.358

4.  Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma.

Authors:  Setareh Sanati; Sahar Taghavi; Khalil Abnous; Seyed Mohammad Taghdisi; Maryam Babaei; Mohammad Ramezani; Mona Alibolandi
Journal:  Gene Ther       Date:  2021-02-25       Impact factor: 5.250

Review 5.  Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.

Authors:  Zhaoying Fu; Jim Xiang
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 6.  Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging.

Authors:  Mengping Liu; Lin Wang; Young Lo; Simon Chi-Chin Shiu; Andrew B Kinghorn; Julian A Tanner
Journal:  Cells       Date:  2022-01-04       Impact factor: 6.600

7.  Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer.

Authors:  Maliheh Hasannia; Khalil Abnous; Seyed Mohammad Taghdisi; Sirous Nekooei; Mohammad Ramezani; Mona Alibolandi
Journal:  J Nanobiotechnology       Date:  2022-08-31       Impact factor: 9.429

Review 8.  Prospects of Curcumin Nanoformulations in Cancer Management.

Authors:  Hilda Amekyeh; Enas Alkhader; Rayan Sabra; Nashiru Billa
Journal:  Molecules       Date:  2022-01-07       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.